The PLI for Bulk Drugs has enhanced domestic manufacturing of Key Starting Materials (KSMs), Drug Intermediates (DIs), and ...

Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be ...

National innovation asset will be strategically located at technology partner Cygnet Texkimp’s site in Northwich ...

Menopausal Hormone Therapy (MHT) is first-line treatment for the relief of menopausal symptoms. Although the majority of ...